{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:08:42Z","timestamp":1789837722413,"version":"4.0.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.tem.2023.08.018","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:14:42Z","timestamp":1695226482000},"page":"849-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Detection, mechanisms, and therapeutic implications of oncometabolites"],"prefix":"10.1016","volume":"34","author":[{"given":"Ying","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-4472","authenticated-orcid":false,"given":"Aihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.08.018_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41574-022-00773-5","article-title":"Metabolic determinants of tumour initiation","volume":"19","author":"Brunner","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2023.08.018_bb0010","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1039\/D0CS01075H","article-title":"Gadolinium theranostics for the diagnosis and treatment of cancer","volume":"50","author":"Robertson","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.tem.2023.08.018_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105577","article-title":"Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: a multicentre experience","volume":"123","author":"Fussey","year":"2021","journal-title":"Oral Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.survophthal.2021.08.007","article-title":"Conjunctival myxoma: a systematic review of a rare tumor","volume":"67","author":"Alvarado-Villacorta","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.tem.2023.08.018_bb0025","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/0008-5472.CAN-22-0917","article-title":"Metabolic reprogramming in hematologic malignancies: advances and clinical perspectives","volume":"82","author":"Yu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/annrheumdis-2021-eular.3585","article-title":"POS0398\u202fadiponectin induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling","volume":"80","author":"Wang","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tem.2023.08.018_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41581-019-0210-z","article-title":"Oncometabolites in renal cancer","volume":"16","author":"Yong","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tem.2023.08.018_bb0040","first-page":"333","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tem.2023.08.018_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tem.2023.08.018_bb0050","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-20-2562","article-title":"Hypoxia-driven oncometabolite L-2HG maintains stemness-differentiation balance and facilitates immune evasion in pancreatic cancer","volume":"81","author":"Gupta","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/neuonc\/noac155","article-title":"The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas","volume":"25","author":"Natsume","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.tem.2023.08.018_bb0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature24294","article-title":"BCAT1 restricts \u03b1KG levels in AML stem cells leading to IDHmut-like DNA hypermethylation","volume":"551","author":"Raffel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0065","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.3390\/ijms232113561","article-title":"MK2 promotes the development and progression of pancreatic neuroendocrine tumors mediated by macrophages and metabolomic factors","volume":"23","author":"Jacenik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2023.08.018_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tem.2023.08.018_bb0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42255-023-00736-8","article-title":"PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages","volume":"5","author":"Schilperoort","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tem.2023.08.018_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tem.2023.08.018_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cac2.12112","article-title":"New insights into molecules and pathways of cancer metabolism and therapeutic implications","volume":"41","author":"Tang","year":"2021","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.tem.2023.08.018_bb0090","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1373\/clinchem.2016.267666","article-title":"Oncometabolites: a new paradigm for oncology, metabolism, and the clinical laboratory","volume":"63","author":"Collins","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2023.08.018_bb0095","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1200\/JCO.2019.37.15_suppl.1524","article-title":"Tumor mutation burden and PD-L1 expression in SDH\/FH mutated solid tumors","volume":"37","author":"Drusbosky","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.05.038","article-title":"Mutant IDH1 promotes phagocytic function of microglia\/macrophages in gliomas by downregulating ICAM1","volume":"517","author":"Ma","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tem.2023.08.018_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","article-title":"Metabolic coordination of cell fate by \u03b1-ketoglutarate-dependent dioxygenases","volume":"31","author":"Baksh","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tem.2023.08.018_bb0110","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.abj5104","article-title":"Oncometabolite d-2HG alters T cell metabolism to impair CD8(+) T cell function","volume":"377","author":"Notarangelo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tem.2023.08.018_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0120","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.molcel.2022.01.029","article-title":"Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma","volume":"82","author":"Ge","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tem.2023.08.018_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12967-022-03292-z","article-title":"In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy","volume":"20","author":"Lu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0135","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/cancers13122900","article-title":"Metabolic rewiring and the characterization of oncometabolites","volume":"13","author":"Beyo\u011flu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tem.2023.08.018_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0145","article-title":"Oncometabolite fingerprinting using fluorescent single-walled carbon nanotubes","volume":"9","author":"Amir","year":"2022","journal-title":"Adv. Mater. Interfaces"},{"key":"10.1016\/j.tem.2023.08.018_bb0150","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41592-022-01572-6","article-title":"Advances in measuring cancer cell metabolism with subcellular resolution","volume":"19","author":"Ruiz-Rodado","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tem.2023.08.018_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101355","article-title":"Imaging mass spectrometry reveals tumor metabolic heterogeneity","volume":"23","author":"Zhang","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.tem.2023.08.018_bb0160","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/1078-0432.CCR-21-4383","article-title":"Spatial metabolomics identifies distinct tumor-specific subtypes in gastric cancer patients","volume":"28","author":"Wang","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2023.08.018_bb0170","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1038\/s41598-021-91560-1","article-title":"Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma","volume":"11","author":"Pomyen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.08.018_bb0175","first-page":"232","article-title":"Urinary metabolites for urological cancer detection: a review on the application of volatile organic compounds for cancers","volume":"7","author":"Gao","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.tem.2023.08.018_bb0180","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/bioinformatics\/btac303","article-title":"ATHENA: analysis of tumor heterogeneity from spatial omics measurements","volume":"38","author":"Martinelli","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tem.2023.08.018_bb0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jchromb.2019.01.011","article-title":"Development and validation of LC-MS\/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite betadecitabine in human plasma, whole blood and urine","volume":"1109","author":"Roosendaal","year":"2019","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.tem.2023.08.018_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12967-023-03929-7","article-title":"Enterococcus faecalis promotes the progression of colorectal cancer via its metabolite: biliverdin","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jpha.2022.08.004","article-title":"Metabolomic and elemental profiling of blood serum in bladder cancer","volume":"12","author":"Ossoli\u0144ski","year":"2022","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.tem.2023.08.018_bb0200","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339761","article-title":"Single cell mass spectrometry studies reveal metabolomic features and potential mechanisms of drug-resistant cancer cell lines","volume":"1206","author":"Sun","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.tem.2023.08.018_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114643","article-title":"1H NMR-based metabolomics of skin squamous cell carcinoma and peri-tumoral region tissues","volume":"212","author":"Mei","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tem.2023.08.018_bb0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11306-022-01968-7","article-title":"Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis","volume":"19","author":"Zhang","year":"2023","journal-title":"Metabolomics"},{"key":"10.1016\/j.tem.2023.08.018_bb0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-05661-6","article-title":"Slow TCA flux and ATP production in primary solid tumours but not metastases","volume":"614","author":"Bartman","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0225","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-21-2855","article-title":"Metabolomic biomarkers in blood samples identify cancers in a mixed population of patients with nonspecific symptoms","volume":"28","author":"Larkin","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0230","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1038\/s41467-021-26685-y","article-title":"Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma","volume":"12","author":"Nie","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.08.018_bb0235","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1200\/JCO.2022.40.16_suppl.3049","article-title":"Serum concentrations of oncometabolite, 2-hydroxyglutarate (2HG), as biomarkers for isocitrate dehydrogenase (IDH1\/2) mutations in cholangiocarcinoma (ICCA)","volume":"40","author":"Lee","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0240","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/s41467-020-16810-8","article-title":"Using arterial-venous analysis to characterize cancer metabolic consumption in patients","volume":"11","author":"Xiong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.08.018_bb0245","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/cancers13071727","article-title":"Succinate anaplerosis has an onco-driving potential in prostate cancer cells","volume":"13","author":"Sant'Anna-Silva","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2023.08.018_bb0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0255","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s42255-023-00781-3","article-title":"The GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells","volume":"5","author":"Talwar","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tem.2023.08.018_bb0260","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.08.018_bb0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2021.09.024","article-title":"The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer","volume":"176","author":"Fontana","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0275","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.3748\/wjg.v26.i34.5074","article-title":"Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors","volume":"26","author":"Zhao","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tem.2023.08.018_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100926","article-title":"FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis","volume":"67","author":"Li","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tem.2023.08.018_bb0285","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","article-title":"Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth","volume":"27","author":"Jin","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","article-title":"Breast cancer cells rely on environmental pyruvate to shape the metastatic niche","volume":"568","author":"Elia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0295","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","article-title":"The effect of HIF on metabolism and immunity","volume":"18","author":"Taylor","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tem.2023.08.018_bb0300","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/cancers13071653","article-title":"Succinate pathway in head and neck squamous cell carcinoma: potential as a diagnostic and prognostic marker","volume":"13","author":"Terra","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2023.08.018_bb0305","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","article-title":"Polyamines in cancer: integrating organismal metabolism and antitumour immunity","volume":"22","author":"Holbert","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tem.2023.08.018_bb0310","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.devcel.2020.06.036","article-title":"Metabolites regulate cell signaling and growth via covalent modification of proteins","volume":"54","author":"Figlia","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0315","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1016\/j.molcel.2022.10.027","article-title":"Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis","volume":"82","author":"Park","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0320","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1016\/j.molcel.2022.10.015","article-title":"Acetyl-CoA, protein acetylation, and liver cancer","volume":"82","author":"Wu","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tem.2023.08.018_bb0325","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.08.018_bb0330","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13046-022-02338-w","article-title":"Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification","volume":"41","author":"Fu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0335","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/pharmaceutics13050762","article-title":"Targeting mitochondrial oncometabolites: a new approach to overcome drug resistance in cancer","volume":"13","author":"Godel","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tem.2023.08.018_bb0340","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","article-title":"Oncometabolites suppress DNA repair by disrupting local chromatin signalling","volume":"582","author":"Sulkowski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0345","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/d41586-020-01569-1","article-title":"Tumour metabolites hinder DNA repair","volume":"582","author":"Chen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0350","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-017-0544-y","article-title":"Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells","volume":"36","author":"Hujber","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0355","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3119375","article-title":"Tumor microenvironment: lactic acid promotes tumor development","volume":"2022","author":"Gao","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.tem.2023.08.018_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tem.2023.08.018_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-022-03215-3","article-title":"Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma","volume":"72","author":"Longhitano","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tem.2023.08.018_bb0370","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/cells12060939","article-title":"Extracellular lactic acidosis of the tumor microenvironment drives adipocyte-to-myofibroblast transition fueling the generation of cancer-associated fibroblasts","volume":"12","author":"Andreucci","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.tem.2023.08.018_bb0375","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41422-022-00650-w","article-title":"SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors","volume":"32","author":"Wang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0380","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.ade3697","article-title":"Metabolite-driven antitumor immunity","volume":"377","author":"Nathan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tem.2023.08.018_bb0385","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.08.018_bb0390","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.3390\/cancers12123642","article-title":"Untargeted metabolomic characterization of ovarian tumors","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2023.08.018_bb0395","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ymthe.2022.01.007","article-title":"D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tem.2023.08.018_bb0400","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood-2021-147099","article-title":"Response prediction to isocitrate dehydrogenase (IDH) inhibitors in patients with IDH1- or IDH2-mutated acute myeloid leukemia using clinical and genomic data","volume":"138","author":"Scott","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tem.2023.08.018_bb0405","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1182\/blood-2018-99-117294","article-title":"The combination of PARP inhibitors and DNMT inhibitors modulates immune activity and suggests a role for immune therapy in AML","volume":"132","author":"Kogan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tem.2023.08.018_bb0410","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(23)00275-9","article-title":"Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study","volume":"24","author":"Pant","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0415","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.tcb.2023.03.008","article-title":"Glucose metabolism of TAMs in tumor chemoresistance and metastasis","volume":"33","author":"Liu","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tem.2023.08.018_bb0420","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13046-020-01669-w","article-title":"Aspartate beta-hydroxylase as a target for cancer therapy","volume":"39","author":"Kanwal","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0425","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41591-022-02163-w","article-title":"Persistent mutation burden drives sustained anti-tumor immune responses","volume":"29","author":"Niknafs","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41417-022-00495-w","article-title":"Application of ATAC-seq in tumor-specific T cell exhaustion","volume":"30","author":"Chen","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tem.2023.08.018_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.811485","article-title":"Vascular microenvironment, tumor immunity and immunotherapy","volume":"12","author":"Lamplugh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.08.018_bb0440","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41586-023-05891-2","article-title":"Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer","volume":"616","author":"Lee","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0445","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0450","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41419-021-04124-6","article-title":"Notch1\/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer","volume":"12","author":"Xie","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tem.2023.08.018_bb0455","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4155\/fmc-2019-0287","article-title":"Structural and functional regulation of lactate dehydrogenase-A in cancer","volume":"12","author":"Woodford","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.tem.2023.08.018_bb0460","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/cas.15468","article-title":"Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation","volume":"113","author":"Du","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tem.2023.08.018_bb0465","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.aav0173","article-title":"Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation","volume":"363","author":"Lee","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tem.2023.08.018_bb0470","doi-asserted-by":"crossref","first-page":"D1259","DOI":"10.1093\/nar\/gkaa1067","article-title":"MarkerDB: an online database of molecular biomarkers","volume":"49","author":"Wishart","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0475","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.csbj.2021.12.002","article-title":"LCMD: Lung Cancer Metabolome Database","volume":"20","author":"Wu","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tem.2023.08.018_bb0480","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1038\/s41598-019-47669-5","article-title":"Quantitative profiling of oncometabolites in frozen and formalin-fixed paraffin-embedded tissue specimens by liquid chromatography coupled with tandem mass spectrometry","volume":"9","author":"Bao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.08.018_bb0485","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fonc.2020.00717","article-title":"LC-MS-based plasma metabolomics and lipidomics analyses for differential diagnosis of bladder cancer and renal cell carcinoma","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0490","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/0008-5472.CAN-21-0384","article-title":"Loss of FBXW7 correlates with increased IDH1 expression in glioma and enhances IDH1-mutant cancer cell sensitivity to radiation","volume":"82","author":"Yang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123085","article-title":"Quantification of succinic acid levels, linked to succinate dehydrogenase (SDH) dysfunctions, by an automated and fully validated liquid chromatography tandem mass spectrometry method suitable for multi-matrix applications","volume":"1189","author":"Lamy","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.tem.2023.08.018_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121740","article-title":"Targeted metabolomics in formalin-fixed paraffin-embedded tissue specimens: liquid chromatography-tandem mass spectrometry determination of acidic metabolites in cancer research","volume":"223","author":"Gomez-Gomez","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.tem.2023.08.018_bb0505","doi-asserted-by":"crossref","first-page":"15217","DOI":"10.1038\/srep15217","article-title":"Sensitive determination of onco-metabolites of D- and L-2-hydroxyglutarate enantiomers by chiral derivatization combined with liquid chromatography\/mass spectrometry analysis","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.08.018_bb0510","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5391832","article-title":"Development of a LC-MS\/MS method for the simultaneous detection of tricarboxylic acid cycle intermediates in a range of biological matrices","volume":"2017","author":"Al Kadhi","year":"2017","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.tem.2023.08.018_bb0515","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","article-title":"Macrophage fumarate hydratase restrains mtRNA-mediated interferon production","volume":"615","author":"Hooftman","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.08.018_bb0520","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1055-9965.EPI-15-0697","article-title":"Aspirin reduces plasma concentrations of the oncometabolite 2-hydroxyglutarate: results of a randomized, double-blind, crossover trial","volume":"25","author":"Liesenfeld","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.tem.2023.08.018_bb0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/14690667221098520","article-title":"GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor","volume":"28","author":"Eroglu","year":"2022","journal-title":"Eur. J. Mass Spectrom. (Chichester)"},{"key":"10.1016\/j.tem.2023.08.018_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121010","article-title":"Metabolic alterations of short-chain fatty acids and TCA cycle intermediates in human plasma from patients with gastric cancer","volume":"309","author":"Kim","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.tem.2023.08.018_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.708052","article-title":"NMR-based metabolomics analysis predicts response to neoadjuvant chemotherapy for triple-negative breast cancer","volume":"8","author":"He","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tem.2023.08.018_bb0540","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1038\/s41598-019-52667-8","article-title":"Correlations between the metabolic profile and (18)F-FDG-positron emission tomography-computed tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients","volume":"9","author":"Vanhove","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.08.018_bb0545","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1021\/acs.analchem.0c05311","article-title":"Successive high-resolution (H(2)O)(n)-GCIB and C(60)-SIMS imaging integrates multi-omics in different cell types in breast cancer tissue","volume":"93","author":"Tian","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tem.2023.08.018_bb0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-021-00242-z","article-title":"Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI","volume":"9","author":"Andersen","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.tem.2023.08.018_bb0555","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/metabo11090599","article-title":"Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging","volume":"11","author":"Denti","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.tem.2023.08.018_bb0560","article-title":"Comparing DESI-MSI and MALDI-MSI mediated spatial metabolomics and their applications in cancer studies","volume":"12","author":"He","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-9831-9_3","article-title":"Analysis of lipids in single cells and organelles using nanomanipulation-coupled mass spectrometry","volume":"2064","author":"Phelps","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tem.2023.08.018_bb0570","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41592-021-01182-8","article-title":"Metabolomic profiling of single enlarged lysosomes","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tem.2023.08.018_bb0575","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41391-019-0180-z","article-title":"Hyperpolarized (13)C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study","volume":"23","author":"Chen","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.tem.2023.08.018_bb0580","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/JCO.2021.39.15_suppl.3001","article-title":"First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors","volume":"39","author":"Yap","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0585","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/blood-2018-08-869008","article-title":"Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib","volume":"133","author":"Stein","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tem.2023.08.018_bb0590","doi-asserted-by":"crossref","first-page":"411","DOI":"10.23736\/S0026-4806.20.07024-X","article-title":"Enasidenib and ivosidenib in AML","volume":"111","author":"Martelli","year":"2020","journal-title":"Minerva Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0595","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.08.018_bb0600","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0605","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg8402","article-title":"Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses","volume":"14","author":"Odunsi","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2023.08.018_bb0610","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.jmedchem.0c01895","article-title":"Discovery of AG-270, a first-in-class oral MAT2A inhibitor for the treatment of tumors with homozygous MTAP deletion","volume":"64","author":"Konteatis","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tem.2023.08.018_bb0615","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41573-022-00538-9","article-title":"The expanding role for small molecules in immuno-oncology","volume":"21","author":"Offringa","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tem.2023.08.018_bb0620","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1021\/acs.jmedchem.0c01398","article-title":"Discovery of IPN60090, a clinical stage selective glutaminase-1 (GLS-1) inhibitor with excellent pharmacokinetic and physicochemical properties","volume":"63","author":"Soth","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tem.2023.08.018_bb0625","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS3149","article-title":"Phase 1 and phase 2a, first-in-human (FIH) study, of DRP-104, a broad glutamine antagonist, in adult patients with advanced solid tumors","volume":"39","author":"Johnson","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0630","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tem.2023.08.018_bb0635","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/1535-7163.MCT-22-0282","article-title":"Sirpiglenastat (DRP-104) induces antitumor efficacy through direct, broad antagonism of glutamine metabolism and stimulation of the innate and adaptive immune systems","volume":"21","author":"Yokoyama","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tem.2023.08.018_bb0640","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.2021.39.15_suppl.e23505","article-title":"Phase II study of SM-88 in Ewing's and other sarcomas","volume":"39","author":"Chua","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0645","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS4156","article-title":"SM-88 in advanced cancers of the pancreas (SMACP)","volume":"36","author":"Noel","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0650","first-page":"15","article-title":"SM-88 efficacy and safety in metastatic breast cancers","volume":"36","author":"Zhu","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.08.018_bb0655","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase II investigation of TVB-2640 (denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2023.08.018_bb0660","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41392-022-01199-1","article-title":"Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tem.2023.08.018_bb0665","doi-asserted-by":"crossref","first-page":"vi23","DOI":"10.1093\/neuonc\/noz175.087","article-title":"Fatty acid synthase inhibitor Tvb-2640 increases progression free survival in recurrent GBM","volume":"21","author":"Konkel","year":"2019","journal-title":"Neuro-Oncology"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:45:46Z","timestamp":1760906746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":133,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1043276023001856"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.08.018","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection, mechanisms, and therapeutic implications of oncometabolites","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}